3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
3
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Upper Tract Urothelial Carcinoma
1
Unresectable Hepatocellular Carcinoma
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Solid Tumor Cancer
1
Sarcoma
1
Radiation Injuries
1
Pathologic Complete Response
1
Pancreatic Cancer Liver Metastases
1
Neoadjuvant Immunotherapy
1
Muscle-invasive Bladder Cancer
1
Locally Advanced Rectal Adenocarcinoma
1
Locally Advanced Pancreatic Cancer
1
Locally Advanced Cervical Carcinoma
1
Hyperthermia
1
HER2-Negative Locally Advanced Breast Cancer
1
Gynecologic Cancers
1
Gastrointestinal Neoplasms
1
Gastric Cancer With Liver Metastases
1
Esophageal Squamous Cell Carcinoma
1
Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer
1
Colorectal Neoplasms
1
Carcinoma
1
Breast Neoplasms
1
Advanced Rectal Cancer
1
Interventions
Surgical Procedures, Operative
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Locally Advanced Rectal Adenocarcinoma
×
Immunotherapy
×
Clear all
NCT07596290
2026-05-22
RADICAL
Beijing Friendship Hospital
Phase 2/3
Not yet recruiting
342 enrolled